Superbugs pose graver threat than Covid-19. Here's all you need to know about antimicrobial resistance

As Covid-19 curve flattens, experts warn about the worrisome spike in drug-resistant superbugs that pose a greater risk that coronavirus and cause negative health outcomes as the bacteria is evolving and becoming resistant to existing antibiotics. With viruses, they often fade away as more people become immune but AMR doesn't work that way.” The emergence of drug-resistant superbugs poses significant challenges to achieving herd immunity. Furthermore, the presence of these superbugs may compromise standard infection control measures like hand hygiene and quarantine protocols, crucial for managing outbreaks and safeguarding herd immunity.” He alerted, “Moreover, vulnerable populations, including older adults and those with weakened immune systems, are disproportionately affected by drug-resistant superbugs, exacerbating the challenges in maintaining herd immunity. In conclusion, the rise of drug-resistant superbugs presents a substantial barrier to achieving and maintaining herd immunity, highlighting the need for comprehensive strategies to tackle this urgent public health issue.” Dr Manjusha Agarwal, Senior Consultant Internal Medicine at Gleneagles Hospitals in Mumbai's Parel, shared, “Some infections caused by bacteria, viruses, fungi and parasites can not be managed with the available medicines in the country. It is better to discuss this with the doctor and ensure you don't overuse medication or self-medicate.” Echoing that the rise of drug-resistant superbugs is a pressing issue that could potentially eclipse the challenges posed by the Covid-19 pandemic, Praveen Sikri, CEO at Ikris Pharma Network, concluded, “These formidable bacteria, resistant to multiple antibiotics, threaten to undermine decades of medical advancements.